The Top Analysis for Gilead Sciences Inc (GILD)
The top analysis was written by Noah Brody titled Which is the Better Buy? Gilead Sciences vs Bristol-Myers Squibb
Is Gilead Sciences Inc (GILD) a buy?
Based on 1 suggestion, Gilead Sciences Inc(GILD) is recommended as a HOLD at $64.92.Are These Ratings Good?
Based on 1 ratings, the average Return is 24.77%.Forecast for Gilead Sciences Inc (GILD)
the two year forecast for GILD is $90.60.
The four year forecast is $94.92